Rothschild & Co Asset Management US’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $139M | Buy |
253,285
+5,129
| +2% | +$2.72M | 2.12% | 4 |
|
|
2022
Q3 | $126M | Sell |
248,156
-18,165
| -7% | -$10.2M | 2.15% | 6 |
|
|
2022
Q2 | $145M | Sell |
266,321
-6,453
| -2% | -$3.55M | 2.22% | 5 |
|
|
2022
Q1 | $161M | Buy |
272,774
+7,318
| +3% | +$4.2M | 2.06% | 7 |
|
|
2021
Q4 | $177M | Sell |
265,456
-4,484
| -2% | -$2.8M | 2.08% | 5 |
|
|
2021
Q3 | $154M | Sell |
269,940
-4,633
| -2% | -$2.54M | 1.91% | 5 |
|
|
2021
Q2 | $139M | Buy |
274,573
+62,437
| +29% | +$29.5M | 1.64% | 8 |
|
|
2021
Q1 | $96.8M | Buy |
212,136
+4,891
| +2% | +$2.33M | 1.19% | 21 |
|
|
2020
Q4 | $96.5M | Buy |
207,245
+77,558
| +60% | +$36.4M | 1.24% | 10 |
|
|
2020
Q3 | $57.3M | Sell |
129,687
-47,315
| -27% | -$19.5M | 1.03% | 9 |
|
|
2020
Q2 | $64.1M | Sell |
177,002
-17,552
| -9% | -$5.88M | 0.94% | 13 |
|
|
2020
Q1 | $55.2M | Sell |
194,554
-25,674
| -12% | -$8.1M | 0.86% | 19 |
|
|
2019
Q4 | $71.5M | Sell |
220,228
-2,763
| -1% | -$838K | 0.74% | 18 |
|
|
2019
Q3 | $65M | Sell |
222,991
-8,021
| -3% | -$2.3M | 0.7% | 22 |
|
|
2019
Q2 | $67.8M | Sell |
231,012
-18,527
| -7% | -$5.1M | 0.72% | 18 |
|
|
2019
Q1 | $68.3M | Sell |
249,539
-3,941
| -2% | -$981K | 0.73% | 18 |
|
|
2018
Q4 | $56.7M | Sell |
253,480
-1,627
| -0.6% | -$382K | 0.68% | 26 |
|
|
2018
Q3 | $62.3M | Sell |
255,107
-14,113
| -5% | -$3.25M | 0.64% | 23 |
|
|
2018
Q2 | $55.8M | Buy |
269,220
+1,763
| +0.7% | +$374K | 0.6% | 32 |
|
|
2018
Q1 | $55.2M | Sell |
267,457
-18,433
| -6% | -$3.87M | 0.61% | 32 |
|
|
2017
Q4 | $54.3M | Sell |
285,890
-51,848
| -15% | -$9.93M | 0.57% | 41 |
|
|
2017
Q3 | $63.9M | Buy |
337,738
+41,969
| +14% | +$7.6M | 0.7% | 27 |
|
|
2017
Q2 | $51.6M | Buy |
295,769
+129,674
| +78% | +$21.8M | 0.58% | 45 |
|
|
2017
Q1 | $25.5M | Sell |
166,095
-8,555
| -5% | -$1.31M | 0.29% | 129 |
|
|
2016
Q4 | $24.6M | Buy |
174,650
+163,005
| +1,400% | +$24M | 0.31% | 114 |
|
|
2016
Q3 | $1.85M | Buy |
11,645
+7,945
| +215% | +$1.22M | 0.03% | 322 |
|
|
2016
Q2 | $547K | Sell |
3,700
-160
| -4% | -$23.6K | 0.01% | 384 |
|
|
2016
Q1 | $547K | Sell |
3,860
-1,734
| -31% | -$232K | 0.01% | 327 |
|
|
2015
Q4 | $794K | Sell |
5,594
-100
| -2% | -$13.3K | 0.01% | 331 |
|
|
2015
Q3 | $696K | Sell |
5,694
-75
| -1% | -$9.77K | 0.01% | 327 |
|
|
2015
Q2 | $749K | Buy |
+5,769
| New | +$752K | 0.01% | 321 |
|
|
2015
Q1 | – | Sell |
-135,205
| Closed | -$17M | – | 350 |
|
|
2014
Q4 | $17M | Buy |
135,205
+2,083
| +2% | +$253K | 0.34% | 91 |
|
|
2014
Q3 | $16.2M | Buy |
133,122
+533
| +0.4% | +$64.8K | 0.35% | 79 |
|
|
2014
Q2 | $15.6M | Sell |
132,589
-47,740
| -26% | -$5.62M | 0.32% | 94 |
|
|
2014
Q1 | $21.7M | Buy |
180,329
+1,333
| +0.7% | +$158K | 0.48% | 51 |
|
|
2013
Q4 | $19.9M | Sell |
178,996
-50,398
| -22% | -$5.01M | 0.44% | 59 |
|
|
2013
Q3 | $21.1M | Buy |
229,394
+1,555
| +0.7% | +$141K | 0.46% | 56 |
|
|
2013
Q2 | $19.3M | Buy |
+227,839
| New | +$19M | 0.45% | 58 |
|
Other funds holding TMO
Rothschild & Co Asset Management US's TMO Position: Q4 2022 in Review
Rothschild & Co Asset Management US increased its Thermo Fisher Scientific (TMO) stake by 2.1% in Q4 2022, buying an estimated $2.72M and bringing the position to 253,285 shares worth $139M. The position accounts for 2.12% of the portfolio, ranked #4.
Rothschild & Co Asset Management US first reported a position in TMO in Q2 2013 and has held it in 38 quarters since. The position peaked at $177M in Q4 2021. 2,375 funds tracked by Wall St. Rank hold TMO as of Q4 2022.
- Rothschild & Co Asset Management US held 253,285 shares of Thermo Fisher Scientific worth $139M as of Q4 2022.
- Rothschild & Co Asset Management US bought 5,129 Thermo Fisher Scientific shares in Q4 2022, an estimated $2.72M.
- Thermo Fisher Scientific made up 2.12% of Rothschild & Co Asset Management US's portfolio in Q4 2022, its #4 holding.
- Rothschild & Co Asset Management US first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 38 quarters since.
- Rothschild & Co Asset Management US's Thermo Fisher Scientific position peaked at $177M in Q4 2021.
- 2,375 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2022.
Based on Rothschild & Co Asset Management US's 13F filing for Q4 2022, filed 14 Feb 2023.